Access cutting-edge glioblastoma treatment through this clinical trial at a research site in New York. Study-provided care at no cost to qualified participants.
Access glioblastoma specialists in New York at no cost
This study follows strict safety protocols and ethical guidelines
All study-related glioblastoma treatment provided free
This research study is studying a combination therapy as a possible treatment for recurrent glioblastoma (GBM), a brain tumor that is growing or progressing despite earlier treatment. The names of the study interventions involved in this study are/is: * Pembrolizumab * Olaparib * Temozolomide (Temodar)
Sponsor: L. Nicolas Gonzalez Castro, MD, PhD
Check if you qualify for this glioblastoma clinical trial in New York, NY
If you're searching for glioblastoma treatment options in New York, NY, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our New York research site is actively enrolling participants for this clinical trial. You'll receive care from experienced glioblastoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.